Paper calls for patient-first regulation of A

<p>A new paper in JAMA describes how, despite widespread enthusiasm about artificial intelligence&#39;s potential to revolutionize healthcare and the use of AI-powered tools on millions of patients already, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients.&nbsp;</p>

Related Keywords

United States ,University Of California San Diego ,California ,San Diego ,Americans ,Davey Smith ,Nimit Desai ,Johnw Ayers ,Translational Research Institute ,Artificial Intelligence In Health Care ,Qualcomm Institute ,Division Of Infectious Disease ,Global Public Health ,Human Services ,Pearl Health ,Department Of Health ,Method Of Research ,Pharma Holdings ,Health Watcher ,Uc San Diego School Of Medicine ,California San Diego ,House Executive Order ,Infectious Disease ,Diego School ,White House Executive Order ,Altman Clinical ,Artificial Intelligence ,Health Care ,Prioritizing Patient Outcomes ,Prioritizing Patient ,Good Analytics ,Model Medicines ,Arena Pharmaceutical ,Red Queen Therapeutics ,Linear Therapies ,